Isorhamnetin and anti-PD-L1 antibody dual-functional mesoporous silica nanoparticles improve tumor immune microenvironment and inhibit YY1-mediated tumor progression | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Isorhamnetin and anti-PD-L1 antibody dual-functional mesoporous silica nanoparticles improve tumor immune microenvironment and inhibit YY1-mediated tumor progression

Authors:: Huijuan Liu; Jingxia Han; Ying Lv; Zihan Zhao; Shaoting Zheng; Yu Sun; Tao Sun

Reference:: Journal of Nanobiotechnology; 2023; 21; 208

DOI:: 10.1186/s12951-023-01967-3

See Abstract

Key Words:: YY1; USP7; molecular docking; isorhamnetin; anti-PD-L1 antibody; mesoporous silica nanoparticles; hepatocellular carcinoma; mice; myeloid derived suppressor cells; animal experiments

Back to index